Literature DB >> 12968735

Development of a polyclonal-antibody-based immunohistochemical method for the detection of type 2 porcine circovirus in formalin-fixed, paraffin-embedded tissue.

S D Sorden1, P A Harms, P Nawagitgul, D Cavanaugh, P S Paul.   

Abstract

An immunohistochemical method for the detection of type 2 porcine circovirus (PCV2) in paraffin-embedded tissue was developed. Rabbits were inoculated with purified PCV2 to obtain a polyclonal antiserum. Antiserum was applied to sections of porcine tissue that contained lesions consistent with postweaning multisystemic wasting syndrome and in which PCV2 genome had been demonstrated by in situ hybridization. In all cases (18/18), the density and distribution of positive cells detected by in situ hybridization or immunohistochemistry were identical. The immunohistochemical method is more rapid and less expensive than in situ hybridization and is thus more suitable for routine diagnostic use.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 12968735     DOI: 10.1177/104063879901100607

Source DB:  PubMed          Journal:  J Vet Diagn Invest        ISSN: 1040-6387            Impact factor:   1.279


  33 in total

1.  Porcine reproductive and respiratory syndrome virus infection at the time of porcine circovirus type 2 vaccination has no impact on vaccine efficacy.

Authors:  A Sinha; H G Shen; S Schalk; N M Beach; Y W Huang; P G Halbur; X J Meng; T Opriessnig
Journal:  Clin Vaccine Immunol       Date:  2010-10-06

2.  Cloned genomic DNA of type 2 porcine circovirus is infectious when injected directly into the liver and lymph nodes of pigs: characterization of clinical disease, virus distribution, and pathologic lesions.

Authors:  M Fenaux; P G Halbur; G Haqshenas; R Royer; P Thomas; P Nawagitgul; M Gill; T E Toth; X J Meng
Journal:  J Virol       Date:  2002-01       Impact factor: 5.103

3.  Porcine circovirus type 2 infection decreases the efficacy of a modified live porcine reproductive and respiratory syndrome virus vaccine.

Authors:  T Opriessnig; N E McKeown; K L Harmon; X J Meng; P G Halbur
Journal:  Clin Vaccine Immunol       Date:  2006-08

4.  Studies on porcine circovirus type 2 vaccination of 5-day-old piglets.

Authors:  K C O'Neill; H G Shen; K Lin; M Hemann; N M Beach; X J Meng; P G Halbur; T Opriessnig
Journal:  Clin Vaccine Immunol       Date:  2011-09-21

5.  Expression of human CD46 has no effect on porcine circovirus type 2 infection and shedding in the experimental pig model.

Authors:  Michelle Hemann; Hui-Gang Shen; Nathan M Beach; Xiang-Jin Meng; Patrick G Halbur; Tanja Opriessnig
Journal:  Vet Res Commun       Date:  2012-03-03       Impact factor: 2.459

6.  The role of immunostimulation in the development of postweaning multisystemic wasting syndrome in pigs under field conditions.

Authors:  Julius Haruna; Paul Hanna; Daniel Hurnik; Basil Ikede; Lisa Miller; Carmencita Yason
Journal:  Can J Vet Res       Date:  2006-10       Impact factor: 1.310

7.  Immunogenicity and pathogenicity of chimeric infectious DNA clones of pathogenic porcine circovirus type 2 (PCV2) and nonpathogenic PCV1 in weanling pigs.

Authors:  M Fenaux; T Opriessnig; P G Halbur; X J Meng
Journal:  J Virol       Date:  2003-10       Impact factor: 5.103

8.  Identification and functional analysis of the novel ORF4 protein encoded by porcine circovirus type 2.

Authors:  Jialing He; Jingjing Cao; Niu Zhou; Yulan Jin; Jiusheng Wu; Jiyong Zhou
Journal:  J Virol       Date:  2012-11-14       Impact factor: 5.103

9.  Effect of porcine circovirus type 2 (PCV2) vaccination of the dam on PCV2 replication in utero.

Authors:  D M Madson; A R Patterson; S Ramamoorthy; N Pal; X J Meng; T Opriessnig
Journal:  Clin Vaccine Immunol       Date:  2009-04-08

10.  Porcine circovirus type 2 (PCV2)-infection and re-inoculation with homologous or heterologous strains: virological, serological, pathological and clinical effects in growing pigs.

Authors:  Tanja Opriessnig; John R Prickett; Darin M Madson; Hui-Gang Shen; Nicole M Juhan; Roman R Pogranichniy; Xiang-Jin Meng; Patrick G Halbur
Journal:  Vet Res       Date:  2010-01-18       Impact factor: 3.683

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.